Vitamin K epoxide reductase: Difference between revisions
Content deleted Content added
Luckas-bot (talk | contribs) m robot Adding: ja:ビタミンKエポキシドレダクターゼ |
No edit summary |
||
| Line 31: | Line 31: | ||
[[ja:ビタミンKエポキシドレダクターゼ]] |
[[ja:ビタミンKエポキシドレダクターゼ]] |
||
[[it:Vitamina K epossido reduttasi]] |
|||
Revision as of 20:36, 18 June 2010
| vitamin K epoxide reductase complex, subunit 1 | |
|---|---|
| Identifiers | |
| Symbol | VKORC1 |
| Alt. symbols | VKCFD2 |
| NCBI gene | 79001 |
| HGNC | 23663 |
| RefSeq | NM_024006 |
| Other data | |
| Locus | Chr. 16 p11.2 |
Vitamin K epoxide reductase (VKOR) is an enzyme (EC 1.1.4.1) that reduces vitamin K after it has been oxidised in the carboxylation of glutamic acid. Its C1 subunit (VKORC1) is the target of anticoagulant warfarin.[1][2]
References
- ^ Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature 2004;427(6974):541-4. PMID 14765195.
- ^ Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hortnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, Muller CR, Strom TM, Oldenburg J. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427(6974):537-41. PMID 14765194.